Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
PubMed PMID: 26185454
NI-57 was used at 10 µM final concentration in vitro and in cellular assays
Indiplon in the treatment of sleep disorders
10 mM SB431542
Ledipasvir - CAS# 1256388-51-8 0153 PubMed PMID: 26185454Ledipasvir, also known as GS 5885, CAS No. 1256388 51 8, is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg sofosbuvir 400 mg (trade name Harvoni). The ledipasvir sofosbuvir combination is a direct acting antiviral agent that interferes with HCV replication and can be used to treat
US$ 25.00
US$ 88.99
US$ 199.00
US$ 90.95
US$ 49.99
US$ 78.00
US$ 81.95
US$ 11.99